The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Archean Chemical Industries Limited is an India-based specialty chemical manufacturing company. The Company is engaged in activities related to the production and supply of marine chemicals. It is a producer and exporter of Bromine, Sulfate of Potash, and Industrial Salt. It…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak, stagnant business, fully valued.
Archean Chemical Ind is scored on the general / industrial framework. It keeps a slim 9.5% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.32× reported profit. Free cash flow is worth about -3.0% of its market value.
Over the last 3 years revenue compounded at -9%/yr and profit at -35%/yr. Book value has grown 11%/yr. Return on equity is a weak 5.1%. In the latest quarter profit grew 3% versus the prior quarter.
At 48× earnings, the stock sits at the 71st percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price already implies ~22%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 52.51 | — | — |
| P/B | 2.62 | 2.66 | better |
| EV/EBITDA | 22.29 | 9.95 | worse |
| ROE | 5.08 | — | — |
| ROCE | 6.53 | — | — |
| ROA | 3.46 | — | — |
| Quick Ratio | 0.72 | 2.26 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 59.1 | 14.3 | 23.9% |
| SRF | 32.3 | 4.8 | 14.9% |
| Linde India | 118.3 | 13.3 | 11.3% |
Negative CAGR — the top line has shrunk over this window. Growth is accelerating — latest year outpaced the prior year's rate.
Revenue is outpacing profit (-9% vs -35%) — costs are rising faster than the top line. The latest year saw a -35% swing — check if it's a one-off or structural.
Operating margin has compressed from 34% to 13% — costs or competition are eating into profitability. Interest or tax burden is shrinking — more of the operating profit is reaching the bottom line. Margins have declined for 3 consecutive years — watch for a structural cost problem.
ROE at 5% — modest; the capital isn't working hard. Capital efficiency declining — ROE down 21pp.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. Profit grew faster than EPS (-35% vs -37%) — share dilution is eroding per-share value. -37% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.3× PAT — earnings are well-backed by cash; strong accrual quality. Investing outflows exceed operating cash — the company relies on external funding to finance expansion.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue fell 9% QoQ — could be seasonality or a genuine slowdown. Run-rate stepping up — recent quarters average 12% above earlier ones.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoter holding at 53.4% — majority control intact.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.